²¹¹At-OKT10-B10 and Fludarabine Alone or in Combination With Cyclophosphamide and Low-Dose TBI Before Donor Stem Cell Transplant for the Treatment of Newly Diagnosed, Recurrent, or Refractory High-Risk Multiple Myeloma
Conditions
- Multiple Myeloma
- Recurrent Multiple Myeloma
- Refractory Multiple Myeloma
Interventions
- PROCEDURE: Allogeneic Hematopoietic Stem Cell Transplantation
- BIOLOGICAL: Astatine At 211 Anti-CD38 Monoclonal Antibody OKT10-B10
- DRUG: Cyclophosphamide
- DRUG: Fludarabine Phosphate
- RADIATION: Total-Body Irradiation
- PROCEDURE: Biospecimen Collection
- PROCEDURE: Bone Marrow Aspiration
- PROCEDURE: Bone Marrow Biopsy
- PROCEDURE: X-Ray Imaging
Sponsor
Fred Hutchinson Cancer Center
Collaborators